Century Therapeutics (IPSC) Revenue (2022 - 2025)

Century Therapeutics (IPSC) reported Revenue of $109.2 million for Q1 2025, up 12667.72% year-over-year from N/an in Q1 2024, and up 2515.96% on a QoQ basis from $4.2 million in Q4 2024.

Century Therapeutics (IPSC) has 4 years of Revenue data on file, last reported at $109.2 million in Q1 2025.

  • Quarterly Revenue rose 12667.72% year-over-year to $109.2 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $109.2 million (up 1556.51% YoY) and the FY2025 annual result came in at $109.2 million, up 1556.76% from the prior year.
  • Revenue grew to $109.2 million in Q1 2025 per IPSC's latest filing, from $4.2 million in the prior quarter.
  • Across five years, Revenue topped out at $109.2 million in Q1 2025 and bottomed at $99000.0 in Q2 2023.
  • The 4-year median for Revenue is $855000.0 (2024), against an average of $9.5 million.
  • The widest annual swing landed in 2023, when Revenue slumped 93.35%; it then jumped 12667.72% in 2025.
  • Tracing IPSC's Revenue over 4 years: stood at $521000.0 in 2022, then sank by 48.56% to $268000.0 in 2023, then surged by 1457.09% to $4.2 million in 2024, then soared by 2515.96% to $109.2 million in 2025.
  • Per Business Quant, the three latest IPSC Revenue figures stand at $109.2 million (Q1 2025), $4.2 million (Q4 2024), and $791000.0 (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.17 Bn
10 Century Therapeutics 474.01 Mn 474.01 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 109.16 Mn
Dec 31, 2024 4.17 Mn
Sep 30, 2024 791,000.00
Jun 30, 2024 771,000.00
Mar 31, 2024 855,000.00
Dec 31, 2023 268,000.00
Sep 30, 2023 148,000.00
Jun 30, 2023 99,000.00
Mar 31, 2023 1.72 Mn
Dec 31, 2022 521,000.00
Sep 30, 2022 2.22 Mn
Jun 30, 2022 1.40 Mn
Mar 31, 2022 1.06 Mn